Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Women'S Health (2002)
|
May 15, 2015
The impact of multimorbidity on quality of life among midlife women: findings from a U.S. nationally representative survey
Kathleen Lang, Ivy M Alexander, James Simon, et al.
RMD Open
|
February 5, 2019
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond
Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 28, 2020
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
Dafna D Gladman, Ana-Maria Orbai, Juan Gomez-Reino, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients
Ann Hsu, Jeffrey Isaacson, Scott Brun, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
November 30, 2007
Zebrafish ae2.2 encodes a second slc4a2 anion exchanger
Boris E Shmukler, Jeffrey S Clark, Ann Hsu, et al.
Patient Preference and Adherence
|
July 2, 2020
Treatment Mode Preferences in Psoriatic Arthritis: A Qualitative Multi-Country Study
Daniel Aletaha, M Elaine Husni, Joseph F Merola, et al.
The Lancet. Rheumatology
|
January 27, 2024
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Peter Nash, Laura C Coates, Dona Fleishaker, et al.
Journal of the Neurological Sciences
|
January 30, 2017
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease
James Tetrud, Paul Nausieda, David Kreitzman, et al.
Blood Cells, Molecules & Diseases
|
December 14, 2019
Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia
Boris E Shmukler, Alicia Rivera, Parul Bhargava, et al.
Dermatology and Therapy
|
December 31, 2020
Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD
Rebecca Hall, Mark G Lebwohl, Andrew G Bushmakin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Women'S Health (2002)
|
May 15, 2015
The impact of multimorbidity on quality of life among midlife women: findings from a U.S. nationally representative survey
Kathleen Lang, Ivy M Alexander, James Simon, et al.
RMD Open
|
February 5, 2019
Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond
Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 28, 2020
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
Dafna D Gladman, Ana-Maria Orbai, Juan Gomez-Reino, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients
Ann Hsu, Jeffrey Isaacson, Scott Brun, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
November 30, 2007
Zebrafish ae2.2 encodes a second slc4a2 anion exchanger
Boris E Shmukler, Jeffrey S Clark, Ann Hsu, et al.
Patient Preference and Adherence
|
July 2, 2020
Treatment Mode Preferences in Psoriatic Arthritis: A Qualitative Multi-Country Study
Daniel Aletaha, M Elaine Husni, Joseph F Merola, et al.
The Lancet. Rheumatology
|
January 27, 2024
Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Peter Nash, Laura C Coates, Dona Fleishaker, et al.
Journal of the Neurological Sciences
|
January 30, 2017
Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease
James Tetrud, Paul Nausieda, David Kreitzman, et al.
Blood Cells, Molecules & Diseases
|
December 14, 2019
Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia
Boris E Shmukler, Alicia Rivera, Parul Bhargava, et al.
Dermatology and Therapy
|
December 31, 2020
Development and Content Validation of Pruritus and Symptoms Assessment for Atopic Dermatitis (PSAAD) in Adolescents and Adults with Moderate-to-Severe AD
Rebecca Hall, Mark G Lebwohl, Andrew G Bushmakin, et al.
Page
of 7